Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term outcome of the unrestricted use of everolimus-eluting stents compared to sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients: the Bern-Rotterdam diabetes cohort study.
Simsek C, Räber L, Magro M, Boersma E, Onuma Y, Stefanini GG, Zanchin T, Kalesan B, Wenaweser P, Jüni P, van Geuns RJ, van Domburg RT, Windecker S, Serruys PW. Simsek C, et al. Among authors: zanchin t. Int J Cardiol. 2013 Dec 5;170(1):36-42. doi: 10.1016/j.ijcard.2013.10.006. Epub 2013 Oct 12. Int J Cardiol. 2013. PMID: 24196314
Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents.
Pilgrim T, Kalesan B, Zanchin T, Pulver C, Jung S, Mattle H, Carrel T, Moschovitis A, Stortecky S, Wenaweser P, Stefanini GG, Räber L, Meier B, Jüni P, Windecker S. Pilgrim T, et al. Among authors: zanchin t. EuroIntervention. 2013 Jan 22;8(9):1061-71. doi: 10.4244/EIJV8I9A163. EuroIntervention. 2013. PMID: 23339812 Free article.
Impact of stent overlap on long-term clinical outcomes in patients treated with newer-generation drug-eluting stents.
O'Sullivan CJ, Stefanini GG, Räber L, Heg D, Taniwaki M, Kalesan B, Pilgrim T, Zanchin T, Moschovitis A, Büllesfeld L, Khattab AA, Meier B, Wenaweser P, Jüni P, Windecker S. O'Sullivan CJ, et al. Among authors: zanchin t. EuroIntervention. 2014 Jan 22;9(9):1076-84. doi: 10.4244/EIJV9I9A182. EuroIntervention. 2014. PMID: 24064474 Free article. Clinical Trial.
Differential healing response attributed to culprit lesions of patients with acute coronary syndromes and stable coronary artery after implantation of drug-eluting stents: an optical coherence tomography study.
Räber L, Zanchin T, Baumgartner S, Taniwaki M, Kalesan B, Moschovitis A, Garcia-Garcia HM, Justiz J, Pilgrim T, Wenaweser P, Meier B, Jüni P, Windecker S. Räber L, et al. Among authors: zanchin t. Int J Cardiol. 2014 May 1;173(2):259-67. doi: 10.1016/j.ijcard.2014.02.036. Epub 2014 Feb 28. Int J Cardiol. 2014. PMID: 24631113
The association between in-stent neoatherosclerosis and native coronary artery disease progression: a long-term angiographic and optical coherence tomography cohort study.
Taniwaki M, Windecker S, Zaugg S, Stefanini GG, Baumgartner S, Zanchin T, Wenaweser P, Meier B, Jüni P, Räber L. Taniwaki M, et al. Among authors: zanchin t. Eur Heart J. 2015 Aug 21;36(32):2167-76. doi: 10.1093/eurheartj/ehv227. Epub 2015 Jun 3. Eur Heart J. 2015. PMID: 26040806 Free article. Clinical Trial.
Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trial.
Yamaji K, Räber L, Zanchin T, Spitzer E, Zanchin C, Pilgrim T, Stortecky S, Moschovitis A, Billinger M, Schönenberger C, Eberli F, Jüni P, Lüscher TF, Heg D, Windecker S. Yamaji K, et al. Among authors: zanchin t, zanchin c. Eur Heart J. 2016 Dec 1;37(45):3386-3395. doi: 10.1093/eurheartj/ehw343. Epub 2016 Aug 30. Eur Heart J. 2016. PMID: 27578808 Free article. Clinical Trial.
Effects of coronary artery disease in patients undergoing transcatheter aortic valve implantation: A study of age- and gender-matched cohorts.
Franzone A, Stortecky S, Räber L, Heg D, Yamaji K, Piccolo R, Asami M, Lanz J, Praz F, Koskinas K, Zanchin T, Wenaweser P, Valgimigli M, Jüni P, Pilgrim T, Windecker S. Franzone A, et al. Among authors: zanchin t. Int J Cardiol. 2017 Sep 15;243:150-155. doi: 10.1016/j.ijcard.2017.05.071. Epub 2017 May 17. Int J Cardiol. 2017. PMID: 28536005
Incidence and predictors of outcomes after a first definite coronary stent thrombosis.
Tovar Forero MN, Zanchin T, Masdjedi K, van Zandvoort LJC, Kardys I, Zijlstra F, Häner J, Windecker S, Van Mieghem NM, Räber L, Daemen J. Tovar Forero MN, et al. Among authors: zanchin t. EuroIntervention. 2020 Jul 17;16(4):e344-e350. doi: 10.4244/EIJ-D-19-00219. EuroIntervention. 2020. PMID: 31475906 Free article.
Additive effect of anemia and renal impairment on long-term outcome after percutaneous coronary intervention.
Pilgrim T, Rothenbühler M, Kalesan B, Pulver C, Stefanini GG, Zanchin T, Räber L, Stortecky S, Jung S, Mattle H, Moschovitis A, Wenaweser P, Meier B, Gsponer T, Windecker S, Jüni P. Pilgrim T, et al. Among authors: zanchin t. PLoS One. 2014 Dec 9;9(12):e114846. doi: 10.1371/journal.pone.0114846. eCollection 2014. PLoS One. 2014. PMID: 25489846 Free PMC article.
54 results